Company intelligence / Profile preview

Wuhan Dahua Weiye Pharmaceutical Chemical

Wuhan, Hubei, China

Ownership: Private
Development stage: Other

Overview

Wuhan Dahua Weiye Pharmaceutical Chemical is a Chinese enterprise specializing in the research, development, production, and sale of active pharmaceutical ingredients (APIs), pharmaceutical intermediates, and fine chemicals. Based in Wuhan, the company provides a wide range of products including steroid hormones, local anesthetics, and nutritional supplements to global markets. Their facilities are equipped for large-scale chemical synthesis and quality control, catering to the pharmaceutical and biotechnology industries. The company operates primarily as a B2B supplier and contract manufacturer for chemical raw materials and bulk substances.

Modalities: Small molecule
Industry: Contract Manufacturing Organization

Beyond the preview

Go deeper on Wuhan Dahua Weiye Pharmaceutical Chemical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Wuhan Dahua Weiye Pharmaceutical Chemical.

Explore the full profile